# Targeting Cancer Survival Genes in Solid Tumors

Page: https://stenobird.com/podcast/the-bio-report-1092382/targeting-cancer-survival-genes-in-solid-tumors
Text version: https://stenobird.com/podcast/the-bio-report-1092382/targeting-cancer-survival-genes-in-solid-tumors.md
Podcast: [The Bio Report](https://stenobird.com/podcast/the-bio-report-1092382)
Published: 2026-05-13T07:00:00+00:00
Episode link: https://thebioreport.podbean.com/e/targeting-cancer-survival-genes-in-solid-tumors/
Audio file: https://mcdn.podbean.com/mf/web/7kysmtqar95uzrwc/BR-Robert_Schickel-5-14-269l0as.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/targeting-cancer-survival-genes-in-solid-tumors
Duration seconds: 2750

## Resource

Most cancer therapies hit one or a few pathways that tumors can escape by mutating, activating alternative survival routes, or pumping drugs out, leading to relapse and poor survival in indications such as liver, ovarian, and prostate cancer. Nuago is developing single-construct short RNAs that simultaneously silence many survival genes in cancer cells to achieve durable tumor cell killing with minimal toxicity to normal tissue. Nuago CEO Robert Schickel discusses the biology behind toxic RNA seeds and tumor-suppressive microRNAs; the company’s lead programs in liver, ovarian, and prostate cancer; and the implications if its cancer-agnostic RNA platform can live up to its preclinical promise.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/targeting-cancer-survival-genes-in-solid-tumors/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-bio-report-1092382/targeting-cancer-survival-genes-in-solid-tumors.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.